GACM
FURX

Global Alpha Capital Management’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Global Alpha Capital Management’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$3M Buy
67,120
+146
+0.2% +$6K 4.61% 7
2013
Q3 		$3.03M Sell
66,974
-44,272
-40% -$1.83M 4.91% 4
2013
Q2 		$4M Buy
+111,246
New +$3.91M 3.98% 9

Other funds holding FURX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Global Alpha Capital Management's FURX Position: Q4 2013 in Review

Global Alpha Capital Management increased its FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) stake by 0.22% in Q4 2013, buying an estimated $6K and bringing the position to 67,120 shares worth $3M. The position accounts for 4.61% of the portfolio, ranked #7.

Global Alpha Capital Management first reported a position in FURX in Q2 2013 and has held it in 3 quarters since. The position peaked at $4M in Q2 2013. 84 funds tracked by Wall St. Rank hold FURX as of Q4 2013.

  • Global Alpha Capital Management held 67,120 shares of FURIEX PHARMACEUTICALS INC COM STK (DE) worth $3M as of Q4 2013.
  • Global Alpha Capital Management bought 146 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q4 2013, an estimated $6K.
  • FURIEX PHARMACEUTICALS INC COM STK (DE) made up 4.61% of Global Alpha Capital Management's portfolio in Q4 2013, its #7 holding.
  • Global Alpha Capital Management first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and has held it in 3 quarters since.
  • Global Alpha Capital Management's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $4M in Q2 2013.
  • 84 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q4 2013.

Based on Global Alpha Capital Management's 13F filing for Q4 2013, filed 13 Feb 2014.